Your browser doesn't support javascript.
loading
miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5.
Stiegelbauer, Verena; Vychytilova-Faltejskova, Petra; Karbiener, Michael; Pehserl, Anna-Maria; Reicher, Andreas; Resel, Margit; Heitzer, Ellen; Ivan, Cristina; Bullock, Marc; Ling, Hui; Deutsch, Alexander; Wulf-Goldenberg, Annika; Adiprasito, Jan Basri; Stoeger, Herbert; Haybaeck, Johannes; Svoboda, Marek; Stotz, Michael; Hoefler, Gerald; Slaby, Ondrej; Calin, George Adrian; Gerger, Armin; Pichler, Martin.
Afiliação
  • Stiegelbauer V; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Vychytilova-Faltejskova P; Research Unit for Non-Coding RNAs and Genome Editing, Medical University of Graz, Graz, Austria.
  • Karbiener M; Molecular Oncology II - Solid Cancers, Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Pehserl AM; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Czech Republic.
  • Reicher A; Department of Phoniatrics, ENT University Hospital, Medical University of Graz, Graz, Austria.
  • Resel M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Heitzer E; Research Unit for Non-Coding RNAs and Genome Editing, Medical University of Graz, Graz, Austria.
  • Ivan C; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Bullock M; Research Unit for Non-Coding RNAs and Genome Editing, Medical University of Graz, Graz, Austria.
  • Ling H; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Deutsch A; Institute of Human Genetics, Medical University of Graz, Graz, Austria.
  • Wulf-Goldenberg A; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Adiprasito JB; The Center for RNA Interference and Non-coding RNAs, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
  • Stoeger H; Academic Surgery, University of Southampton, Southampton, United Kingdom.
  • Haybaeck J; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Svoboda M; Division of Haematology, Department of Internal Medicine, Medical University of Graz, Austria.
  • Stotz M; Experimental Pharmacology & Oncology GmbH, EPO, Berlin, Germany.
  • Hoefler G; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Slaby O; Research Unit for Non-Coding RNAs and Genome Editing, Medical University of Graz, Graz, Austria.
  • Calin GA; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Gerger A; Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Pichler M; Department of Pathology, Otto von Guericke University Magdeburg, Leipziger Str. 44, D-39120, Magdeburg, Germany.
Clin Cancer Res ; 23(17): 5255-5266, 2017 Sep 01.
Article em En | MEDLINE | ID: mdl-28533224
ABSTRACT

Purpose:

miR-196b-5p has been previously implicated in malignant transformation; however, its role in colorectal cancer has not been fully explored. In this study, we examine the clinical and biological relevance of miR-196b-5p, and the molecular pathways regulated by miR-196b-5p in colorectal cancer.Experimental

Design:

miR-196b-5p expression was quantitated by qRT-PCR in 2 independent cohorts composed of 292 patients with colorectal cancer in total, to explore its biomarker potential. Transient and stable gain- and loss-of-function experiments were conducted in a panel of colorectal cancer cell lines and mice, to evaluate the impact of miR-196b-5p on proliferation, chemosensitivity, migration/invasion, and metastases formation in vitro and in vivo The molecular pathways influenced by miR-196b-5p were characterized using whole transcriptome profiling, in silico target prediction tools, luciferase interaction assays, and phenocopy/rescue gene knockdown experiments.

Results:

Low miR-196b-5p expression was significantly associated with metastases and poor outcomes in 2 independent colorectal cancer patient cohorts (P < 0.05, log-rank test). miR-196b-5p inhibition led to significantly increased colorectal cancer cell migration/invasion and metastases formation in mice, whereas ectopic overexpression showed the opposite phenotype. Molecular profiling and target confirmation identified an interaction between miR-196b-5p and HOXB7 and GALNT5, which in turn regulated colorectal cancer cell migration.

Conclusions:

The association of low levels of miR-196b-5p and poor prognosis in patients with colorectal cancer can be explained by its influence on cancer cell migration and metastases formation. miR-196b-5p has an impact on colorectal cancer progression pathways through direct interaction with genes involved in cancer cell migration. Clin Cancer Res; 23(17); 5255-66. ©2017 AACR.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / N-Acetilgalactosaminiltransferases / Proteínas de Homeodomínio / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / N-Acetilgalactosaminiltransferases / Proteínas de Homeodomínio / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria